1.Overexpression of p-Stat3 and Mcl-1, and their correlation with differentiation and apoptotic resistance in esophageal squamous cell carcinoma.
Yan-qiu HUO ; Xia RUAN ; Xiao-li DU ; Li SHANG ; Yan CAI ; Xin XU ; Ming-rong WANG ; Yu ZHANG ; Song-bin FU
Chinese Journal of Oncology 2013;35(8):579-584
OBJECTIVETo detect the expression of phosphorylated-signal transducer and activator of transcription 3 (p-Stat3) and myeloid leukemia-1 (Mcl-1) as well as their correlation, and to investigate the functional role of Stat3 and Mcl-1 in the pathogenesis of esophageal squamous cell carcinoma (ESCC).
METHODSStat3 activity in ESCC cells was inhibited with JAK/Stat3 inhibitors (AG490 or JSI-124). Specific siRNA was used to inhibit the Stat3 expression. Cell apoptosis was detected by flow cytometry. Expression of Mcl-1 protein was determined by Western blotting. Expression of phospho-Stat3 (Tyr705) and myeloid leukemia-1 (Mcl-1) proteins in ESCC tissues was detected by tissue microarray and immunohistochemistry. The relationship between p-Stat3 or Mcl-1 aberrant expression and clinicopatholohical features of ESCC was analyzed. The correlation of their expression was also analyzed.
RESULTSSuppression of the Stat3 signaling activation in ESCC cells led to marked apoptosis, and dramatic reduction of Mcl-1 protein. The positive rate of phospho-Stat3 (Tyr705) expression was 45.0% in 50/111 of the ESCC tissue samples. The lower the degree of tumor differentiation, the higher the positive rate of phospho-Stat3 (Tyr705), showing a significant difference (P = 0.018). The positive rate of Mcl-1 protein expression was 72.1% (80/111), and the lower the degree of tumor differentiation was, the higher there was the positive rate of Mcl-1, with a significant difference (P = 0.026). There was a positive correlation between the expressions of p-Stat3 and Mcl-1 proteins (P = 0.012).
CONCLUSIONSIn a subset of ESCC tissues, p-Stat3 (Tyr705) and Mcl-1 are overexpressed and positively correlated with each other, and both are correlated with tumor differentiation. Persistent activation of Stat3 contributes to apoptotic resistance in ESCC cells, and may be at least partly mediated through upregulation of Mcl-1.
Antineoplastic Agents ; pharmacology ; Apoptosis ; drug effects ; Carcinoma, Squamous Cell ; metabolism ; pathology ; Cell Differentiation ; Cell Line, Tumor ; Cell Survival ; drug effects ; Esophageal Neoplasms ; metabolism ; pathology ; Humans ; Myeloid Cell Leukemia Sequence 1 Protein ; metabolism ; Neoplasm Grading ; Neoplasm Staging ; Phosphorylation ; RNA, Small Interfering ; genetics ; STAT3 Transcription Factor ; antagonists & inhibitors ; genetics ; metabolism ; Tyrphostins ; pharmacology
2.Knockdown of Bcl-xL Enhances Growth-Inhibiting and Apoptosis-Inducing Effects of Resveratrol and Clofarabine in Malignant Mesothelioma H-2452 Cells.
Yoon Jin LEE ; In Sung HWANG ; Yong Jin LEE ; Chang Ho LEE ; Sung Ho KIM ; Hae Saeon NAM ; Young Jin CHOI ; Sang Han LEE
Journal of Korean Medical Science 2014;29(11):1464-1472
Mcl-1 and Bcl-xL, key anti-apoptotic proteins of the Bcl-2 family, have attracted attention as important molecules in the cell survival and drug resistance. In this study, we investigated whether inhibition of Bcl-xL influences cell growth and apoptosis against simultaneous treatment of resveratrol and clofarabine in the human malignant mesothelioma H-2452 cells. Resveratrol and clofarabine decreased Mcl-1 protein levels but had little effect on Bcl-xL levels. In the presence of two compounds, any detectable change in the Mcl-1 mRNA levels was not observed in RT-PCR analysis, whereas pretreatment with the proteasome inhibitor MG132 led to its accumulation to levels far above basal levels. The knockdown of Bcl-xL inhibited cell proliferation with cell accumulation at G2/M phase and the appearance of sub-G0/G1 peak in DNA flow cytometric assay. The suppression of cell growth was accompanied by an increase in the caspase-3/7 activity with the resultant cleavages of procaspase-3 and its substrate poly (ADP-ribose) polymerase, and increased percentage of apoptotic propensities in annexin V binding assay. Collectively, our data represent that the efficacy of resveratrol and clofarabine for apoptosis induction was substantially enhanced by Bcl-xL-lowering strategy in which the simultaneous targeting of Mcl-1 and Bcl-xL could be a more effective strategy for treating malignant mesothelioma.
Adenine Nucleotides/*pharmacology
;
Antimetabolites, Antineoplastic/*pharmacology
;
Apoptosis/*drug effects
;
Arabinonucleosides/*pharmacology
;
Caspase 3/metabolism
;
Caspase 7/metabolism
;
Cell Line, Tumor
;
Cell Proliferation/drug effects
;
G2 Phase Cell Cycle Checkpoints/drug effects
;
Gene Knockdown Techniques
;
Humans
;
Leupeptins/pharmacology
;
Lung Neoplasms/metabolism/pathology
;
M Phase Cell Cycle Checkpoints/drug effects
;
Mesothelioma/metabolism/pathology
;
Myeloid Cell Leukemia Sequence 1 Protein/antagonists & inhibitors/genetics/metabolism
;
RNA Interference
;
RNA, Messenger/metabolism
;
RNA, Small Interfering/metabolism
;
Stilbenes/*pharmacology
;
bcl-X Protein/antagonists & inhibitors/*genetics/*metabolism
3.Isochamaejasmin induces apoptosis in leukemia cells through inhibiting Bcl-2 family proteins.
Shou-De ZHANG ; Lei SHAN ; Wei LI ; Hong-Lin LI ; Wei-Dong ZHANG
Chinese Journal of Natural Medicines (English Ed.) 2015;13(9):660-666
The biflavonoid isochamaejasmin is mainly distributed in the root of Stellera chamaejasme L. (Thymelaeaceae) that is used in traditional Chinese medicine (TCM) to treat tumors, tuberculosis, and psoriasis. Herein, isochamaejasmin was found to show similar bioactivity against Bcl-2 family proteins to the reference Bcl-2 ligand (-)-gossypol through 3D similarity search. It selectively bound to Bcl-xl and Mcl-1 with Ki values being 1.93 ± 0.13 μmol·L(-1) and 9.98 ± 0.21 μmol·L(-1), respectively. In addition, isochamaejasmin showed slight growth inhibitory activity against HL-60 with IC50 value being 50.40 ± 1.21 μmol·L(-1) and moderate growth inhibitory activity against K562 cells with IC50 value being 24.51 ± 1.62 μmol·L(-1). Furthermore, isochamaejasmin induced apoptosis of K562 cells by increasing the intracellular expression levels of proteins of the cleavage of caspase-9, caspase-3, and PARP which involved in the Bcl-2-induced apoptosis pathway. These results indicated that isochamaejasmin induces apoptosis in leukemia cells by inhibiting the activity of Bcl-2 family proteins, providing evidence for further studying the underlying anti-cancer mechanism of S. chamaejasme L.
Antineoplastic Agents, Phytogenic
;
pharmacology
;
therapeutic use
;
Apoptosis
;
drug effects
;
Biflavonoids
;
pharmacology
;
therapeutic use
;
Caspase 3
;
metabolism
;
Caspase 9
;
metabolism
;
Gossypol
;
pharmacology
;
HL-60 Cells
;
Humans
;
Inhibitory Concentration 50
;
K562 Cells
;
Leukemia
;
drug therapy
;
metabolism
;
Myeloid Cell Leukemia Sequence 1 Protein
;
metabolism
;
Phytotherapy
;
Plant Extracts
;
pharmacology
;
therapeutic use
;
Poly(ADP-ribose) Polymerases
;
metabolism
;
Proto-Oncogene Proteins c-bcl-2
;
antagonists & inhibitors
;
metabolism
;
Signal Transduction
;
Thymelaeaceae
;
chemistry
;
bcl-2-Associated X Protein
;
metabolism